Studies from Food and Drug Administration Have Provided New Data on Flucloxacillin Therapy (Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides)

MLA

“Studies from Food and Drug Administration Have Provided New Data on Flucloxacillin Therapy (Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides).” Obesity, Fitness & Wellness Week, Feb. 2021, p. 1486. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.652550215&authtype=sso&custid=ns315887.

APA

Studies from Food and Drug Administration Have Provided New Data on Flucloxacillin Therapy (Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides). (2021, February 27). Obesity, Fitness & Wellness Week, 1486.

Chicago

Obesity, Fitness & Wellness Week. 2021. “Studies from Food and Drug Administration Have Provided New Data on Flucloxacillin Therapy (Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides),” February 27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.652550215&authtype=sso&custid=ns315887.